Table 3. Univariate analyses on metastatic lymph nodes for the correlation with distribution of metastases (brain, lung, bone or liver).
Brain metastases | Lung metastases | Bone metastases | Liver metastases | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Yes | No | p-value | Yes | No | p-value | Yes | No | p-value | Yes | No | p-value | |
HER2 overexpression (% cases) | 54 | 36 | ns | 31 | 57 | ns | 40 | 47 | ns | 56 | 39 | ns |
ER positivity (% cases) | 8 | 21 | ns | 23 | 7 | ns | 20 | 12 | ns | 0 | 22 | ns |
PR positivity (% cases) | 8 | 7 | ns | 8 | 7 | ns | 20 | 0 | ns | 0 | 11 | ns |
%Ki67-expressing tumor cells | 28 | 18 | < 0.05 | 24 | 22 | ns | 20 | 28 | ns | 21 | 28 | ns |
p16 score in tumor cells | 7 | 1.7 | < 0.001 | 6 | 3 | ns | 4 | 6 | ns | 5 | 5 | ns |